Genetic polymorphisms and the risk of myocardial infarction in patients under 45 years of age

Biochem Genet. 2013 Apr;51(3-4):230-42. doi: 10.1007/s10528-012-9558-5. Epub 2012 Dec 30.

Abstract

This study investigates the potential role of 17 chosen polymorphisms in 15 candidate genes and the risk of myocardial infarction in patients under 45 years of age. The study consists of 271 patients with myocardial infarction and 141 controls. The analysis of genetic polymorphisms was performed using the PCR-RFLP method. Of the chosen polymorphisms, two (Leu125Val PECAM1 and A1/A2 FVII) are related to myocardial infarction and two (C677T MTHFR and 5A/6A MMP3) to advanced stenosis in arterial vessels (> 75%). We also found that the frequency of some combinations among the analyzed genes and environmental factors varied between the patient and control groups.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Atherosclerosis / etiology
  • Atherosclerosis / genetics
  • Female
  • Genetic Carrier Screening
  • Humans
  • Hypertension / genetics
  • Male
  • Matrix Metalloproteinase 3 / genetics
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Middle Aged
  • Myocardial Infarction / etiology
  • Myocardial Infarction / genetics*
  • Polymorphism, Genetic*
  • Risk Factors
  • Smoking / genetics

Substances

  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • MMP3 protein, human
  • Matrix Metalloproteinase 3